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Neurobiology of Disease
Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin
Maintenance and Axon Integrity
XSungsu Kim,1 XJason C. Maynard,3 Yo Sasaki,1 Amy Strickland,1Diane L. Sherman,4 XPeter J. Brophy,4
Alma L. Burlingame,3 and Jeffrey Milbrandt1,2
1Department of Genetics and 2Hope Center for Neurological Diseases, Washington University School of Medicine, St. Louis, Missouri 63110,
3Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94158-2517, and 4Centre for
Neuroregeneration, University of Edinburgh, Edinburgh EH16 4SB, United Kingdom
Schwann cells (SCs), ensheathing glia of the peripheral nervous system, support axonal survival and function. Abnormalities in SC
metabolism affect their ability to provide this support and maintain axon integrity. To further interrogate this metabolic influence on
axon–glial interactions, we generated OGT-SCKO mice with SC-specific deletion of the metabolic/nutrient sensing protein O-GlcNAc
transferase thatmediates the O-linked addition ofN-acetylglucosamine (GlcNAc)moieties to Ser and Thr residues. The OGT-SCKOmice
develop tomaculous demyelinating neuropathy characterized by focal thickenings of the myelin sheath (tomacula), progressive demy-
elination, axonal loss, andmotor and sensory nerve dysfunction. Proteomic analysis identified more than 100 O-GlcNAcylated proteins
in rat sciatic nerve, including Periaxin (PRX), a myelin protein whose mutation causes inherited neuropathy in humans. PRX lacking
O-GlcNAcylation is mislocalized within the myelin sheath of these mutant animals. Furthermore, phenotypes of OGT-SCKO and Prx-
deficient mice are very similar, suggesting that metabolic control of PRX O-GlcNAcylation is crucial for myelin maintenance and axonal
integrity.
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Introduction
Schwann cells (SCs) ensheath peripheral axons and ultimately
support axonal survival and function (Corfas et al., 2004). SC
abnormalities are implicated in peripheral neuropathy (PN), in-
cluding the common inherited neuropathies Charcot-Marie-
Tooth type 1 (CMT1) and hereditary neuropathy with liability to
pressure palsy (HNPP). Despite the identification of many ge-
netic and environmental causes of PN, the mechanisms by which
SCs promote axon integrity remain elusive. Recently, we and
others showed that perturbations of SCmetabolism inmice, such
as those caused by mitochondrial dysfunction or loss of crucial
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Significance Statement
The nutrient sensing protein O-GlcNAc transferase (OGT) mediates post-translational O-linked N-acetylglucosamine (GlcNAc)
modification. Here we find that OGT functions in Schwann cells (SCs) to maintain normal myelin and prevent axonal loss.
SC-specific deletion of OGT (OGT-SCKO mice) causes a tomaculous demyelinating neuropathy accompanied with progressive
axon degeneration and motor and sensory nerve dysfunction. We also found Periaxin (PRX), a myelin protein whose mutation
causes inherited neuropathy in humans, is O-GlcNAcylated. Importantly, phenotypes of OGT-SCKOandPrxmutantmice are very
similar, implying that compromised PRX function contributes to the neuropathy of OGT-SCKOmice. This study will be useful in
understanding how SCmetabolism contributes to PNS function and in developing new strategies for treating peripheral neurop-
athy by targeting SC function.
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energy sensors, lead to axonal loss and peripheral neuropathy
(Nave, 2010; Viader et al., 2011, 2013; Fu¨nfschilling et al.,
2012; Beirowski et al., 2014; Norrme´n et al., 2014; Pooya et al.,
2014; Shen et al., 2014). These observations indicate that SC
metabolism plays a crucial role in the ability of these glial cells
to promote axon health and implicate them in the develop-
ment of neuropathies of metabolic etiology, such as diabetic
peripheral neuropathy.
Metabolic interactions between axons and SCs are thought to
involve Cajal bands, the SC cytoplasm-filled channels present
along myelinated fibers (Nave, 2010). Periaxin (PRX), an abun-
dantly expressed SC protein, mediates the formation of Cajal
bands via promoting the abaxonal apposition of compact myelin
and SC plasma membrane. PRX is concentrated at the abaxonal
(outer surface) appositions where it interacts with dystrophin-
related protein 2 (DRP2; Sherman et al., 2001). Studies ofPrxnull
mice demonstrated a crucial role of PRX in maintaining myelin
stability and controlling internodal length (Gillespie et al., 2000;
Court et al., 2004). Importantly, human PRX mutations are
linked to autosomal recessive peripheral neuropathies CMT4F
andDejerine-Sotas syndrome (DSS), whosemainmorphological
features include focalmyelin thickening (tomacula) and progres-
sive demyelination (Renouil et al., 2013).
O-GlcNAcylation is a post-translational modification in
which a single GlcNAc moiety is attached to Ser or Thr residues
via an O-linkage (Hart and Akimoto, 2009; Bond and Hanover,
2013). O-GlcNAcylation occurs on thousands of proteins and is
involved in awide range of cellular activities, including epigenetic
chromatin modification, transcriptional regulation, and signal
transduction (Vosseller et al., 2006;Ozcan et al., 2010; Trinidad et
al., 2012; Hahne et al., 2013). The GlcNAc addition is catalyzed
by O-GlcNAc transferase (OGT), whereas the removal of the
GlcNAc moiety from the modified Ser/Thr residue is performed
by O-GlcNAcase (OGA, also known as MGEA5; Bond and Ha-
nover, 2015). UDP-GlcNAc, the substrate of OGT, is synthesized
in the hexosamine biosynthetic pathway (HBP), using fructose-
5-phosphate (a glucose derivative), glutamine, acetyl-CoA, and
UTP. The coupling of O-GlcNAcylation to the metabolic flux of
HBP suggests an important role for OGT as a cellular metabolic/
nutrient sensor. Furthermore, this unique form of intracellular
glycosylation has been implicated in diverse human metabolic
syndromes and disorders such as diabetes, cancer, and neurode-
generative diseases (Bond and Hanover, 2013).
We hypothesized that O-GlcNAcylation of key SC proteins
would reflect themetabolic state of these glial cells and could play an
important role in their ability to provide axonal support. To test
this idea, we generated mice with SC-specific deficiency of O-
GlcNAcylation by excising theOGTgene exclusively in SCs (hereaf-
ter called OGT-SCKO mice). OGT-SCKO mice display functional
and morphological phenotypes of demyelinating, tomaculous
peripheral neuropathy. We also analyzed the O-GlcNAcylated
proteomeof rat sciatic nerve usingmass spectrometry (MS). Impor-
tantly, we identified PRX as an O-GlcNAcylated protein and found
that its localization and function is abnormal in OGT-SCKOmice.
PRX is a myelin protein that is mutated in patients with CMT4F,
andPrxmutantmicehave aneuropathywithnervepathology that is
very similar to that observed in OGT-SCKO mice. In summary,
these studies demonstrate a critical role for SC O-GlcNAcylation in
the etiology of peripheral neuropathy.
Materials andMethods
Generation of OGT-SCKOmice. All animal experiments were performed
in compliance with institutional animal protocols. OGT-SCKO mice
(P0-Cre
/, OGT loxP/loxP) and control (Ctrl) littermates (P0-Cre
/,
OGT loxP/loxP) were generated by crossingOGT loxP/loxPmice (O’Donnell
et al., 2004) to P0-Cremice (Feltri et al., 1999). In all experiments,mice of
either sex were used. Mating and genotyping were performed as de-
scribed previously (Viader et al., 2013).
Rotarod test. An accelerating rotarod was used to evaluate motor co-
ordination and balance. Five consecutive acceleration trials were per-
formed with a 5 min interval between trials as described previously
(Viader et al., 2011).
Motor and sensory nerve conduction studies. Motor nerve conduction
studies were performed on mice monthly (up to 8 months old) using a
Viking Quest electromyography machine (Thermo Fisher Scientific) as
described previously (Viader et al., 2011). Briefly,mice were anesthetized
with Avertin and placed on a heating pad. For nerve electrophysiology,
subcutaneous platinum subdermal EEG electrodes (0.4mmdiameter, 12
mm length; Viasys) were used. Stimulating electrodes were placed at the
ankle and the sciatic notch for nerve stimulation. Recording electrodes
were placed in the footpad. Evoked compound motor action potentials
were obtained using supramaximal stimulation, and the distance be-
tween the two sites of stimulating electrodes was used to calculate con-
duction velocity. For tail sensory nerve conduction studies, the recording
electrodes were placed 10 mm distal to the proximal tip of the tail; the
stimulating electrodes were placed 30 mm distal to the recording elec-
trode; the reference electrodes were 10 mm distal to the stimulating
electrodes; and the ground electrodes were placed between the stimulat-
ing and recording electrodes. A train of 15 supramaximal responses to 0.1
ms pulses were recorded and averaged to calculate sensory conduction
amplitude and latency.
Nerve histology andmorphometry. Sciatic nerves fromOGT-SCKOand
littermate control mice of different ages were dissected and placed in 3%
glutaraldehyde overnight. After washing with phosphate buffer, nerves
were postfixed in 1% osmium tetraoxide in phosphate buffer overnight
at 4°C. Specimens were then dehydrated in graded alcohols and embed-
ded in 100% epoxy (Araldite 502). For lightmicroscopy, semithin plastic
embedded sections (300 nm thick) were prepared and stained with tolu-
idine blue. For electron microscopy, ultrathin sections (40–50 nm) were
prepared, stained with uranyl acetate and lead citrate, and imaged with a
JEOL 1200 electronmicroscope. All nerves underwent qualitative assess-
ment of neural architecture followed by detailed histomorphometric
analysis performed as described previously (Viader et al., 2011). Mor-
phometry was performed using ImageJ (NIH), and data processing was
performed using Spotfire (TIBCO).
Immunostaining and confocal microscopy. Sciatic nerves were dissected
and fixed in 4% paraformaldehyde for 1 h at 4°C. The fixed nerves were
cryopreserved in 30% sucrose and embedded in Tissue-Tek OCT Com-
pound (Sakura Finetek) before preparing 6 m sections. For analysis of
teased nerve fibers, mouse sciatic nerves were dissected and fixed in 4%
paraformaldehyde in PBS for 30 min at 4°C. The nerves were washed
three times in PBS for 5 min and desheathed, and nerve bundles were
dissectedwith fine needles in PBS on Fisherbrand Superfrost/Plusmicro-
scope slides. Slides were air-dried for at least 2 h at room temperature and
stored at20°C. For immunostaining, frozen sections were washed and
blocked in 5% fish skin gelatin in PBS with 0.2% Triton for 1 h at room
temperature. Sections were then incubated with a primary antibody di-
luted in blocking buffer overnight at 4°C. Secondary antibody incubation
was performed at room temperature for 1 h also in blocking buffer. The
immunostained sections were mounted with Vectashield mounting me-
dium with DAPI (Vector Laboratories) for microscopic visualization.
Images were captured using an upright microscope equipped for epiflu-
orescence microscopy (Nikon 80i, CoolSnapES camera) and were pro-
cessed usingMetaMorph. Confocal imageswere acquiredwith a confocal
microscope (model C1; Nikon) and accompanying EZ-C1 software us-
ing argon (excitation at 488 nm) and HeNe (excitation at 543 and 633
nm) lasers and a 60  Plan-Apochromat NA 1.4 objective (Nikon) at
room temperature. Samples for each experiment were processed using
the same confocal gain setting unless otherwise specified. All quantifica-
tions were performed with the observer blinded to genotype. ImageJ
(NIH) was used for all quantitative manipulation and analysis of images.
For the quantification of PRX and myelin basic protein (MBP) distribu-
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tion in cross sections of myelinated fibers, pixel intensities of PRX and
MBP on a straight line drawn across the myelin sheath (in a direction
from inside/adaxonal to outside/abaxonal) were measured using ImageJ
Plot Profile. Measurements were aligned according to the coordinate of
peak MBP distribution, and quantification/statistical analyses were per-
formed using Spotfire (TIBCO).
Coimmunoprecipitation and Western blotting. Sciatic nerves were iso-
lated, desheathed in PBS, and immediately frozen in liquid nitrogen.
Nerve lysates were prepared by homogenizing the tissue in a lysis buffer
containing 150 mM sodium chloride, 20 mM Tris-Cl, pH 7.4, 1% Triton
X-100, 1mMEDTA, 1mM sodium fluoride, 1mM sodiumorthovanodate,
and complete protease inhibitor cocktail (Sigma). The lysates were clar-
ified by centrifugation at 14,000 rpm for 10 min at 4°C and quantified
using the MicroBCA Protein Assay kit (Pierce). For coimmunoprecipi-
tation of DRP2 and PRX, the nerve lysates were precleared with protein
A-Sepharose (Sigma) at 4°C for 30min, incubated either with anti-DRP2
or anti-PRX repeat (PRX-R) antibody for 1 h, followed by incubation
with proteinA-Sepharose for an additional 1 h.O-GlcNAcylation of PRX
in HEK 293T cells was analyzed in cells stably expressing FLAG-tagged
PRX. These cells were transfected with human OGT expression vector
and/or treated with 1 M Thiamet-G. Lysates were prepared, and PRX
was immunoprecipitated using FLAG antibody. For Western blotting,
the proteins were separated by SDS-PAGE and transferred to a PVDF
membrane (Millipore). Membranes were blocked in 5% milk in 0.05%
PBS–Tween and incubated overnight with the appropriate primary an-
tibody. After incubation with secondary antibodies conjugated to HRP
(GEHealthcare), membranes were developed withWestern Chemilumi-
nescent HRP Substrate (ECL; EMDMillipore Immobilon). Densitome-
try of the blots was performed using ImageJ.
Antibodies. The following antibodies were used at the indicated dilu-
tion. For Western blot: O-GlcNAc RL2 (1:1000; Abcam), PRX-N (1:
2000; Dytrych et al., 1998), PRX-R (1:10,000; Dytrych et al., 1998), DRP2
(1:3000; Sherman et al., 2001), GAPDH (1:1000; Cell Signaling Technol-
ogy), -actin (1:1000; Sigma), FLAG (1:1000; Sigma), -tubulin E7 (1:
1000; Developmental Studies Hybridoma Bank), and Dystroglycan 
IIH6 C4 (1:100; Developmental Studies Hybridoma Bank). For immu-
nostaining: O-GlcNAc RL2 (1:200; Novus Biologicals), S100 (1:1000;
Dako),MBP (1:1000;Millipore), andNAV1.6K87A/10 (1:100;UCDavis
NeuroMab Facility).
Lectin weak affinity chromatography. Lectin weak affinity chromatog-
raphy (LWAC) and MS analysis of O-GlcNAc proteome was described
previously (Vosseller et al., 2006; Trinidad et al., 2012). Briefly, rat sciatic
nerves from four adult rats (6 months old) were isolated, desheathed in
ice-cold PBS, and flash-frozen in liquid nitrogen. Frozen tissues were
mixed with 500 l of Trizol reagent (Ambion, Life Technologies) and
lysed by sonication on ice, and proteins were extracted according to the
manufacturer’s protocol. The resulting protein pellets were solubilized in
8 M urea, 0.2% Zwittergent 3–16 (Calbiochem), 100 mM ammonium
bicarbonate, pH 8.0, 4  Phosphatase Inhibitor Cocktails I and III
(Sigma), and 20 M PUGNAc. The mixture was reduced for 30 min at
57°C with 5 mM dithiothreitol and subsequently carbamidomethylated
using 10mM iodoacetamide for 30min at room temperature in the dark.
Lysates were diluted to 2 M urea with 100 mM ammonium bicarbonate,
pH 8.0, and digested overnight at 37°C with sequencing-grade trypsin
(Promega) at an enzyme-to-substrate ratio of 1:50 (w/w). After diges-
tion, samples were acidified with formic acid (Sigma-Aldrich) and sub-
sequently desalted using a 360 mg C18 Sep-Pak SPE cartridge (Waters).
Desalted samples were dried to completeness using a SpeedVac concen-
trator (Thermo Electron). Desalted sciatic nerve tryptic peptides were
resuspended in 400 l of LWAC buffer (100 mM Tris, pH 7.5, 150 mM
NaCl, 10 mM MgCl2, 10 mM CaCl2, and 5% acetonitrile). Glycopeptides
were enriched with a POROS-WGA column, collected, and desalted in-
line using a Luna 10 C18 column (Phenomenex). A total of three
rounds of LWAC enrichment were performed. LWAC-enriched glyco-
peptideswere subsequently fractionated by high-pH reverse-phase liquid
chromatography.
Mass spectrometry analysis. All samples were analyzed on an Orbitrap
Velos (Thermo Fisher Scientific) equipped with a nano-Acquity UPLC
(Waters). Peptides were fractionated on a 15 cm 75 m ID 3 mC18
EASY-Spray column using a linear gradient from 2 to 35% solvent B over
60 min. Survey mass measurements were performed using the Orbitrap,
scanning from m/z 350–2000. The three most abundant multiply
charged ions were computer selected for higher energy collisional disso-
ciation (HCD) and electron transfer dissociation (ETD) analysis. The
trigger intensity was set to 2000. Supplemental activation was enabled.
The ETD fragments were measured in the linear trap, whereas HCD
fragments were measured in the Orbitrap. Each sample was injected
twice; the first analysis selected only 2 precursor ions, and in the second
analysis, 2 precursor ions were excluded. Peaklists were extracted using
ProteomeDiscoverer 1.4. ETD data were searched twice against the Uni-
Prot Rattus norvegicus database (downloaded June 6, 2013) (and con-
catenated with a randomized sequence for each entry) using Protein
Prospector (version 5.10.15). Cleavage specificity was set as tryptic, al-
lowing for twomissed cleavages. Carbamidomethylation ofCyswas set as
a constant modification. The required mass accuracy was 5 ppm for
precursor ions and 0.8 Da for ETD fragments. Both searches included
acetylation of protein N termini; oxidation of Met; cyclization of
N-terminal Gln; andHexNAcmodificationof Ser, Thr, andAsn, as variable
modifications. The first search also allowed for the following extended N-
linked glycans on Asn: HexNAc2, HexNAc2Hex2, HexNAc2Hex2Fuc,
HexNAc2Hex2Fuc, HexNAc2Hex3, HexNAc2Hex3Fuc, HexNAc2Hex4,
HexNAc2Hex4Fuc, HexNAc2Hex5, HexNAc2Hex5Fuc, HexNAc2Hex6,
HexNAc2Hex7, HexNAc2Hex8, HexNAc2Hex9, HexNAc3Hex3Fuc,
HexNAc3Hex5Fuc, HexNAc3Hex5FucSA, HexNAc4Hex3Fuc, HexNAc
4Hex4Fuc2, HexNAc4Hex4SA, HexNAc4Hex5Fuc, HexNAc4Hex5Fuc2,
HexNAc4Hex6Fuc, HexNAc5Hex3Fuc, HexNAc5Hex4Fuc, HexNAc5
Hex4Fuc2, HexNAc5Hex4SA, HexNAcFuc. The second search allowed for
the following extended O-linked glycans on Ser and Thr: HexNAc2,
HexNAc2Hex2, HexNAcFuc, HexNAcHex, HexNAcHexSA, HexNAcH-
exSA2, HexNAcSA, as well as HexNAc andHexNAc2 on Asn. Three modi-
ficationsperpeptidewerepermitted.HCDdatawere searchedwith the same
parameters except that fragment ionmass accuracywas 30ppmand theonly
glycans set as variablemodificationswereHexNAconAsn, Ser, andThr and
as a neutral loss. Modified peptides were identified with a protein and
peptide false discovery rate of 1%. O-GlcNAc and O-GalNAc modifica-
tions were differentiated based on protein localization and HexNAc ox-
onium ion fragment ratios (Halim et al., 2014). Results can be viewed in
MS_Viewer [http://prospector2.ucsf.edu/prospector/cgi-bin/msform.
cgi?formmsviewer (search keys: ETD, ntrqixzaiv; HCD, fcx3docywo);
Baker and Chalkley, 2014].
Statistics.Data are represented asmean SEM, unless otherwise spec-
ified. Statistical tests were performed with Spotfire (TIBCO) and Excel
2010 (Microsoft). Groups of means were compared using one-way
ANOVA, and comparisons between two means were performed using
Student’s t test. Significance was as *p 0.05; **p 0. 01; ***p 0.001;
ns, not significant.
Results
OGT deficiency causes abnormal glucose metabolism in
Schwann cells
OGT is the sole enzyme catalyzing O-GlcNAcylation in mam-
malian cells. To study the role of O-GlcNAcylation in
Schwann cell function and peripheral nerve biology, we gen-
erated SC-specific OGT knock-out mice (OGT-SCKO). Mice
carrying loxP flanked alleles of OGT (OGT loxP; Shafi et al.,
2000) were crossed with mice expressing Cre recombinase in
SCs (P0-Cre mice) (Feltri et al., 1999; Shafi et al., 2000). OGT-
SCKO mice were born at the expected Mendelian ratio and
developed normally without any overt morphological or be-
havioral abnormalities. However, beginning 6 months of
age they develop gait abnormalities, muscle weakness, and
hindlimb clasping, a typical presentation of neuromuscular
dysfunction in mice (Fig. 1A).
We examined OGT levels in the mutant nerve, and, as ex-
pected, we detected substantially reduced levels of OGT in sciatic
nerve lysates from 1-month-old OGT-SCKOmice (Fig. 1B). The
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remaining OGT signal in these mutant nerves is likely derived
from non-SC elements (e.g., axons and other cell types such as
fibroblasts, endothelial cells, and resident macrophages). In con-
cert with the loss of OGT, the levels of total O-GlcNAcylation
were similarly decreased inOGT-SCKOnerves (Fig. 1C), indicat-
ing that OGT deficiency in SCs results in loss of protein
O-GlcNAcylation in these glia. To confirm the loss of OGT spe-
cifically in SCs, we performed immunohistochemistry using an
anti-O-GlcNAc antibody. Strong O-GlcNAc immunoreactivity
was detected in SCs (S100 positive) as well as other cell types
(S100 negative) in control sciatic nerves. However, in OGT-
SCKO nerves, O-GlcNAc staining was lost in the SCs but was still
present in the S100-negative cells (Fig. 1D), reflecting the success-
ful and specific excision of OGT in SCs. Although OGT is re-
ported to be critical for cell viability and proliferation in many
tissues and cell types (Shafi et al., 2000;O’Donnell et al., 2004), we
observed no death or altered proliferation in SCs lacking OGT
(data not shown).
SC O-GlcNAcylation is required for peripheral nerve function
The hindlimb clasping observed in OGT-SCKO mice prompted
us to perform additional tests of neuromuscular function.Motor
function was evaluated using the rotarod test. We found that
OGT-SCKOmice performed poorly on this test with a latency to
fall of 40 10 s versus 69 18 s in littermate controls (Student’s
t test, p 0.02). To directly assess peripheral nerve function, we
performed motor nerve conduction studies in mice of different
ages (Fig. 2). At 1month of age, compoundmuscle action poten-
tials (CMAPs) in the sciatic nerve were subtly but significantly
delayed inOGT-SCKOmice (Fig. 2A,B). The slowed conduction
velocity in these mutant mice deteriorated further with increas-
ing age. It is notable that nerve conduction was relatively stable at
20 m/s until 3 months of age but then plummeted dramati-
cally over the next couple of months. This is particularly notable
because conduction velocities ofwild-typemice typically increase
during this period (note increase in control mice from 1 to 5
months of age), coincident with the formation andmaturation of
compact myelin (Viader et al., 2011; Wu et al., 2012). These
results indicate that the deficits in conduction velocity in
OGT-SCKO sciatic nerve are likely attributable to myelin abnor-
malities. In addition to changes in conduction velocity, we also
noted a decrease in the CMAP amplitude, an indicator of axonal
integrity (Fig. 2A,C). The diminished CMAP amplitude contin-
Figure 1. OGT-SCKO mice have deficits in O-GlcNAcylation and glucose metabolism. A, OGT-SCKO mice at 8 months of age show hindlimb clasping, a common sign of peripheral neuropathy in
mice. B, C, Western blot analysis of OGT expression (B) and O-GlcNAcylation (C) in sciatic nerves from 1-month-old control and OGT-SCKO mice. D, Representative confocal microscopic images of
sciatic nerves from1-month-old OGT-SCKO and controlmice stained for O-GlcNAc (green), S100 (red), andDAPI (blue). Intense nuclear O-GlcNAc immunoreactivity is detectable in S100-positive SCs
(arrows) andnon-SCs (arrowheads) in the control nerve (Ctrl),whereasO-GlcNAc staining is absent in S100-positive SCs in theOGT-SCKOnerve (ogt). NoteO-GlcNAc staining innon-SCs in themutant
nerve (arrowheads). Scale bar, 10m.
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ued to decline in older OGT-SCKOmice, indicating the progres-
sive nature of the underlying axonopathy.
To assess the function of sensory nerves, we measured sen-
sory nerve action potentials (SNAPs) in the tail nerve of
2-month-old OGT-SCKO mice. We found the SNAP signal
had increased latency and decreased amplitude compared with
littermate controls (Fig. 2D–F ) and was virtually undetectable
at 3 months of age (data not shown). These results are consis-
tent with the presence of both defective myelin and impaired
axonal integrity in the sensory nerves of these mutant mice.
Interestingly, the total lack of sensory responses in 3-month-
old OGT-SCKO mice contrasts sharply with the only slightly
diminished motor responses at this age. The earlier appear-
ance of sensory versus motor deficits is similar to that seen in
mice in which the SCs lack either liver kinase B1 or mitochon-
drial transcription factor A (Viader et al., 2013; Beirowski et
Figure 2. Impaired motor and sensory nerve functions in OGT-SCKO mice. A–C, Motor nerve conduction studies performed on OGT-SCKO and littermate control mice at the indicated ages. A,
Representative traces of CMAP from 6-month-old OGT-SCKO and control mice recorded at the footpad muscle and stimulated either at ankle or at sciatic notch. B, C, Quantification of conduction
velocity (m/s;B) and amplitude (mV, sciatic/ankle; C) at the indicated ages; n 4–5mice per genotype at each age.D–F, Sensory nerve conduction studies on 2-month-old control and OGT-SCKO
mice.D, Representative traces of tail SNAP. E, F, Quantification of SNAP latency (ms; E) and SNAP amplitude (mV; F ); n 3mice per genotype. Data represented as mean SEM. Student’s t test:
***p 0.001; **p 0.01; *p 0.05.
Kim et al. • SC O-GlcNAcylation Promotes Myelin and Axon Integrity J. Neurosci., September 14, 2016 • 36(37):9633–9646 • 9637
Figure 3. OGT-SCKO mutant mice develop tomaculous demyelinating neuropathy. A, B, Toluidine blue-stained semithin cross section (A) and longitudinal section (B) of sciatic nerves from
3-month-old OGT-SCKO and control mice. A, In cross section, note the numerous dark profiles corresponding to tomacula. B, In the longitudinal section, (Figure legend continues.)
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al., 2014), supporting the idea that the function and integrity
of sensory fibers are more dependent on SC metabolism than
are larger motor axons.
OGT-SCKO develop tomaculous demyelinating peripheral
neuropathy and axonal loss
To examine the morphological features that underlie the nerve
dysfunction in OGT-SCKO mice, we performed nerve histology
and morphometry at various ages (Fig. 3). A macroscopic cross-
sectional view of the sciatic nerve from OGT-SCKOmice clearly
shows the presence of many darkly stained myelin abnormalities
consistent with a tomaculous neuropathy (Fig. 3A). Consistent
with our functional assays, the appearance of these abnormalities
is age dependent: a 1-month-old nerve shows few abnormalities,
whereas nerves from older mice show numerous tomacula, or
focal thickenings of the myelin sheath, and progressive axonal
loss (Fig. 3D–F). The focal thickenings are most frequently ob-
served in the juxtaparanodal/paranodal regions as seen in semi-
thin longitudinal sections and teased fiber preparations of
mutant nerve (Fig. 3B,C). Similar to tomacula formation in hu-
man patients and other animal models (Gillespie et al., 2000;
Sander et al., 2000), these tomaculous fibers have myelin with
abnormal and redundant folds. The ensheathed axons are dis-
torted and of small diameter, characteristics ostensibly attribut-
able to the compressive nature of the myelin in-foldings (Fig.
3D,H). We quantified myelin thickness by calculating the
g-ratio, the ratio of the inner axonal diameter to the outer diam-
eter of the myelinated fiber (Fig. 3E,F). Small-diameter axons in
3-month-old OGT-SCKO nerves had a lower g-ratio compared
with nerves in control animals, confirming the association of
smaller-caliber axons with thick, tomaculousmyelin (Fig. 3E,F).
The larger-diameter axons had a higher g-ratio (thinner myelin)
in themutant animals. Indeed, electronmicroscopy of these mu-
tant nerves clearly revealed axons surrounded by abnormal and
redundant folds of the myelin sheath (Fig. 3H). At 6 months of
age, naked and hypomyelinated nerve fibers prevail in themutant
nerves, consistent with the lower g-ratio for the entire axon pro-
file (Fig. 3D–F). We consistently observed fewer axons in OGT-
SCKO nerves in sharp contrast to wild-type nerves that are fully
occupied by axons. This loss of axons is rapidly progressive as
determined by quantification of myelinated axons at multiple
ages (Fig. 3G). Interestingly, nerves fromOGT-SCKOmiceman-
ifest a significant degree of axonal degeneration at 3 months, an
age when there are no signs of demyelination (Fig. 3D–G), sug-
gesting that axon loss is not a consequence of demyelination.
Together, our morphological analyses demonstrate that SC
O-GlcNAcylation is required for the structural integrity and
maintenance ofmyelin as well as the support of peripheral axons.
Furthermore, the morphological abnormalities of OGT-SCKO
nerves are consistent with the deficits observed in our functional
studies (Fig. 2).
Mass spectrometry analysis of the O-GlcNAc proteome from
rat sciatic nerves
More than 3000O-GlcNAcylated proteins have been identified in
various tissues and cell types, but their abundance and signifi-
cance in the peripheral nervous system is unknown. To identify
O-GlcNAcylated proteins in SCs, we established an O-GlcNAc
proteome from adult rat sciatic nerves. The O-GlcNAc-modified
peptides were enriched using LWAC, and the recovered glyco-
peptides were subsequently processed for analysis by MS (Trini-
dad et al., 2012). In the MS analysis, a total of 212 glycosylated
(N- andO-linked) proteinswere identified, and 123 of themwere
O-GlcNAc modified. A total of 295 unique O-GlcNAc peptides
were identified with 132 unambiguous sites of modification (da-
taset available in MS_viewer; see Materials and Methods for de-
tails). The majority of O-GlcNAcylated proteins (110 of 123) in rat
sciatic nerve are similarly modified in other tissues (Trinidad et al.,
2012).KyotoEncyclopedia ofGenes andGenomes pathway analysis
on the SNO-GlcNAcproteome indicated enrichment in focal adhe-
sion (Ppp1r12a, Flnb, Itgb4, Itga7, Tln1, and Tln2; Bonferroni’s ad-
justed p (adjP)  0.0008) and MAPK signaling (Hspb1, FlnB,
Mapk8ip1, andTab1; adjP 0.0492), implicating a potential role of
O-GlcNAcylation in cytoskeletal organization, cell motility, prolif-
eration, and survival. In addition, the SN O-GlcNAc proteome in-
cludes 16 transcription factors, consistent with O-GlcNAcylation-
dependent regulation of gene expression (Ozcan et al., 2010).
We also identified a small set of O-GlcNAcylated proteins that
appear specific to sciatic nerve as they are not present in our
previously analyzed brain synaptosome (Trinidad et al., 2012).
These proteins included AMBRA1, EHBP1L1, FILIP1, FOXO1,
Irf2bpl, ITGB4, Kansl3, Lin54, MAFK, PAMR1, PLEKHA4, and
PRX. Among them, PRX is particularly interesting as an OGT
target because it is almost exclusively and abundantly expressed
in SCs (Gillespie et al., 1994; Maddala et al., 2011; Patzig et al.,
2011). Additionally,mutations inPRX cause a tomaculous demy-
elinating peripheral neuropathy in humans that appears similar
to that observed in OGT-SCKO mice (see below). We mapped
five O-GlcNAc modifications of rat PRX at residues T657, T755,
T1051, S1052, and T1064, all of which are conserved in human
andmouse PRX (Fig. 4A,B). O-GlcNAcylation frequently occurs
in the unstructured region of a target protein (Trinidad et al.,
2012); accordingly, all of the O-GlcNAc modifications on PRX
are located within the repeat and acidic regions that lack any
known structural fold. We found no O-GlcNAcylated sites in
either the PDZ domain or the basic motif at the N terminus that
directly mediate protein–protein interactions and are thought to
guide the subcellular localization of PRX (Gillespie et al., 1994;
Scherer et al., 1995; Sherman et al., 2001). To confirm the OGT-
dependent O-GlcNAcylation of PRX, we performed immunopre-
cipitation experiments. As expected, PRX from wild-type sciatic
nerves was O-GlcNAcylated, whereas no O-GlcNAcylation was de-
tected on PRX from OGT-SCKO nerves (Fig. 4C). In contrast, the
PRX interacting protein DRP2 is not O-GlcNAcylated (Fig. 4D).
Finally, we confirmed the O-GlcNAcylation of PRX using FLAG-
4
(Figure legend continued.) note the focal hypermyelination/tomacula (asterisks) at paran-
odal/juxtaparanodal regions in OGT-SCKO nerves (ogt). Arrows denote the node of Ranvier.
Scale bars: A, 100m; B, 10m. C, Differential interference contrast image of teased sciatic
nerve fibers from 3-month-old control and OGT-SCKO mice. White arrows indicate node of
Ranvier; red asterisks denote tomacula at paranodal/juxtaparanodal region. Scale bar, 10m.
D, Toluidine blue-stained semithin cross sections of sciatic nerves from OGT-SCKO and control
mice at 1, 3, and 6 months of age. In OGT-SCKO nerves, note the abnormal folds (tomacula) of
hypermyelinated fibers (asterisks) at 3months of age and thenakedandhypomyelinatedaxons
(arrows) aswell as axonal loss at 6monthsof age. Scalebar, 10m.E,F, Scatter plot analysis (E)
andmodified bubble chart (F) of g-ratio versus axon diameter for themyelinated fibers inD. In
F, axons from 3 to 9 m in diameter are grouped into 10 bins. The g-ratio is represented as
mean SEM for each bin. The size of the circle is scaled according to the total number of axons
at the indicated size for each genotype; n 3mice per genotype at the indicated age. Note the
morphometric profiles of tomaculous small-diameter axons with lower g-ratios as well as hy-
pomyelinated large-diameter axons with higher g-ratios in 3-month-old OGT-SCKO nerves. In
6-month-old OGT-SCKO nerves, axons of all sizes are hypomyelinated as reflected by the higher
g-ratio. G, Quantification of the number of myelinated fibers per unit area at the indicated age
in D. Data are represented as mean SEM. Student’s t test, **p 0.01; n 3 mice per
genotypeat eachage.H, Electronmicrographof sciatic nerve in the cross section from3-month-
old control and OGT-SCKO mice. Tomaculum is indicated by the asterisk. Scale bar, 1m.
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PRX-expressingHEK293 cells treatedwith theOGA inhibitorThia-
met-G and transfected with OGT (Fig. 4E).
Phenotype of OGT-SCKO and Prx-deficient mice are similar
Recessively inherited PRXmutations are causally associated with
the human peripheral neuropathy syndromes CMT4F and DSS
(Fig. 4A). The morphological and clinical features present in pa-
tients with CMT4F and DSS include tomacula formation, demy-
elination, axonal loss, and abnormal motor and sensory nerve
conduction studies (Renouil et al., 2013). These symptoms are
similar to those observed in OGT-SCKO mice, as well as those
previously reported in studies of Prx-deficient mice (Gillespie et
al., 2000). Indeed, we find striking similarities in the phenotypes
of OGT-SCKO and Prx mutant mice. We directly compared
nerve pathology in these mice at 1, 3, and 9 months of age. We
found no significant axon loss ormorphological abnormalities in
Figure 4. PRX is O-GlcNAcylated at multiple sites by OGT. A, Schematic representation of PRX domains, O-GlcNAcylation sites, and residues mutated in hereditary neuropathy. Three
O-GlcNAcylated PRX peptides (red) and five O-GlcNAcylated Ser and Thr residues (asterisks) were identified by mass spectrometry (MS/ETD) analysis of rat sciatic nerve O-GlcNAc proteome. PRX
functional domains and sequence features are indicated in blue. Human PRXmutations associated with CMT4F and DSS are indicated in magenta. B, ETD spectrum of precursor ion 607.3303 (3)
m/z identified as the PRX peptide 1050-VTSGVKPSGLQVSTTR-1065 O-GlcNAcylated (HexNAc) at Thr-1065. ETD fragment ions are labeled (c and z) and depicted on the peptide sequence. The
precursor ion (#) and its charge-reduced form (*) are also indicated.C,D,Western blot analysis of PRXO-GlcNAcylation in sciatic nerves from1-month-old Ctrl andOGT-SCKO (ogt)mice. Nerve lysates
were immunoprecipitated using PRX, DRP2, or control IgG antibodies. O-GlcNAcylation, PRX, and DRP2 were detected by Western blotting with anti-O-GlcNAc RL2, anti-PRX-N, and anti-DRP2
antibodies, respectively (as indicated). Note O-GlcNAcylated PRX in sciatic nerve lysates from Ctrl but not from OGT-SCKO (ogt) mice. O-GlcNAcylation of DRP2 is undetectable both in control and
OGT-SCKO nerve lysates. E, Western blot analysis of PRX O-GlcNAcylation in HEK 293T cells. FLAG-tagged PRX (FLAG-Prx) is O-GlcNAcylated in HEK 293T cells expressing exogenous OGT and treated
with the OGA inhibitor Thiamet-G. IP, Immunoprecipitation.
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1-month-old animals of either genotype. We observed extensive
tomacula formation and moderate axon loss starting at 2–3
months of age in both Prx and OGT-SCKO mutant mice (Fig.
5A). At 9 months of age, axonal loss was severe in both mutants,
and there was evidence of hypomyelination/demyelination (Fig.
5A). Quantification of the myelinated axons per nerve (n 3 for
each genotype) revealed that the progression of axon loss in both
mutants was very similar. At 3months, the number ofmyelinated
axons per nerve is 4255 79 in wild-typemice, 3585 101 (15%
loss) in Prx mutant mice, and 3478  142 (18% loss) in OGT-
SCKO mice. At 9 months, the number of myelinated axons per
nerve is 4046 201 in wild-type mice, 2497 134 (38% loss) in
Prx mutant mice, and 2597  167 (35% loss) in OGT-SCKO
mice. These similarities suggest a common pathogenic mecha-
nism underlying the progression and severity of the tomaculous
demyelinating peripheral neuropathy in these mutants (Gillespie
et al., 2000). Together with the identification of PRX as an
O-GlcNAcylated protein in ourMS/ETD study, these phenotypic
parallels led us to hypothesize that disruption of PRX function in
OGT-SCKO mice contributes to the development of their pe-
ripheral neuropathy.
We investigated whether specific functions of PRX are dis-
rupted in OGT-SCKO mice. DRP2 directly interacts with PRX,
and together they form a complex with Dystroglycan at the abax-
onal (outer surface) appositions located between compactmyelin
and SC plasma membrane along myelinated fibers (Sherman et
al., 2001). Interestingly, DRP2 is no longer localized to these ab-
axonal appositions in Prx-deficient mice (Sherman et al., 2001).
We therefore examined whether SC O-GlcNAcylation affects
DRP2 subcellular localization using immunohistochemistry on
teased fiber preparations of sciatic nerves. In control nerves,
DRP2 localizes to spheroidal clusters along the myelinated fibers
(Fig. 5B), representing its concentration at abaxonal appositions
(Sherman et al., 2001, 2012). However, few DRP2-postive appo-
sitions are observed in OGT-SCKO nerves; instead, the majority
of DRP2 is diffusely distributed around the SC perinuclear cyto-
plasm (Fig. 5B). This mislocalization of DRP2 in the OGT-SCKO
nerves is highly reminiscent ofPrxmutant nerves (Sherman et al.,
2001, 2012), indicating that O-GlcNAcylation in SCs is impor-
tant for the formation of abaxonal membrane appositions.
The free flow of molecules within the SC cytoplasm occurs via
small channels known as Cajal bands that are demarcated by the
abaxonal appositions that lie between compact myelin and the
plasma membrane. We used electron microscopy to further in-
vestigate the effects of OGT loss on abaxonal membrane apposi-
tions. At 1 month of age, there are, on average, three membrane
appositions per myelinated axon in control mice (Fig. 5C, Ctrl,
arrowheads; Court et al., 2004). In contrast, themajority of SCs in
OGT-SCKO nerves lack these appositions and hence the normal
compartmentalization of their cytoplasm (Fig. 5C,D). Instead,
the SC cytoplasmic space runs around the entire circumference of
the axon, similar to the situation in myelinated fibers of Prxmu-
tant mice (Court et al., 2004). This deficit indicates that SC
O-GlcNAcylation is critical for formation of abaxonal apposi-
tions of the myelin sheath and hence the establishment of cyto-
plasmic channels (Cajal bands) along myelinated fibers.
In addition to its role in abaxonal apposition formation, PRX
controls the cell-autonomous process of SC elongation along the
length of the myelinated fiber as demonstrated by the shortened
internodes in nerves of Prx mutant mice (Court et al., 2004).
Importantly, Drp2 mutant mice have normal internodal dis-
tances (Sherman et al., 2012); thus, in contrast to formation of
abaxonal appositions, PRX-dependent SC elongation does not
require DRP2. To test whether SC elongation is affected in OGT-
SCKOmice, we quantified the internodal lengths in sciatic nerve
fibers. Teased fiber preparations were immunostained with anti-
bodies to the voltage-gated sodium channel (NAV1.6) to identify
nodes of Ranvier andMBP to mark the internodes (see representa-
tive image in Fig. 5E). The average internodal length inOGT-SCKO
mice was 344 202mversus 733 115m in littermate control
mice (Student’s t test, p 0.001, n 3 mice per genotype and 10
fibers per mouse). The significant shortening of the internode is
strikingly reminiscent of that observed inPrxmutantmice (Court et
al., 2004) and implies thatO-GlcNAcylation is required for thePRX-
dependent SC elongation process. Furthermore, O-GlcNAcylation
affects PRX functions that are independent ofDRP2, indicating that
lack of O-GlcNAcylation in SCs leads to defects in both DRP2-
dependent and -independent PRX functions.
O-GlcNAcylation promotes PRX localization at abaxonal
appositions along mature myelinated fibers
Several important functions of PRX appear to be disrupted by
lack of O-GlcNAcylation, but how this modification promotes
PRX activity is unclear. Some transcription factors are stabilized
by O-GlcNAcylation; thus, OGT deficiency can lead to decreased
protein levels through enhanced degradation (Cheng and Hart,
2001; Zhang et al., 2003; Zhu et al., 2015). To test whether PRX
might be destabilized by lack of O-GlcNAC modification, we
examined its expression in sciatic nerves from 1-month-old
OGT-SCKO mice. PRX was present at roughly equivalent levels
inOGT-SCKOversus littermate control sciatic nerve (Fig. 6A,B).
Although there was a slight, statistically insignificant decrease
(15%) in the mutant nerve, it is unlikely to be functionally
important as humans and mice heterozygous for mutant PRX
alleles do not manifest any abnormalities (Gillespie et al., 2000;
Renouil et al., 2013). Hence, changes in PRX stability caused by
lack of O-GlcNAcylation cannot explain the nerve phenotype in
OGT-SCKO mice.
We expanded our Western blot analysis to include other pro-
teins associated with PRX. Strikingly, the level of DRP2, the only
protein known to interact directly with PRX, was significantly
decreased in sciatic nerves from 1-month-old OGT-SCKO mice
(Fig. 6A,B). In contrast, levels of Dystroglycan , another com-
ponent of the DRP2-Dystroglycan complex at the SC plasma
membrane, were unchanged in OGT-SCKO nerves. The lower
level of DRP2 in OGT-SCKO mice is similar to the specific and
concomitant loss of DRP2 in Prxmutant mice; further support-
ing the idea that SC O-GlcNAcylation deficiency mimics loss of
PRX function. Notably, DRP2 from OGT-SCKO nerve lysates
migrated faster on SDS-PAGE than DRP2 from control nerve
lysates. This increased DRP2 electrophoretic mobility was also
observed in Prxmutantmice and is attributable to reducedDRP2
phosphorylation (Sherman et al., 2012). The interaction between
PRX and DRP2 is thought to be necessary for DRP2 phosphory-
lation (Sherman et al., 2012), suggesting that O-GlcNAcylation
might regulate the DRP2–PRX interaction.
In addition toDRP2phosphorylation, its interactionwithPRX is
required for formation of abaxonal appositions inmyelinated fibers
(Sherman et al., 2012). To investigate whether PRXmodification by
O-GlcNAcylation alters its interaction with DRP2, we performed
coimmunoprecipitation experiments using sciatic nerve lysates
from 1-month-old control and OGT-SCKO mice (Fig. 6C,D). We
found that unmodified PRX was still capable of binding DRP2, al-
thoughtherewasa slightbut reproducibledecrease in the interaction
between PRX and DRP2 in OGT-SCKO nerve. These results indi-
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Figure 5. Abaxonal apposition formation and internodal length are abnormal in OGT-SCKO nerves. A, Representative toluidine blue-stained semithin cross sections of sciatic nerves from Ctrl,
OGT-SCKO (ogt), and Prx-null ( prx) mice at 3 and 9months of age. Note the decrease in the number of axons in the mutant animals and the presence of tomacula (asterisks) and thinly myelinated
fibers (arrows). Scale bar, 10m.B, Representative confocalmicroscopic images of teased sciatic nerve fibers from1-month-oldOGT-SCKOand controlmice labeled for DRP2 (green) andMBP (red).
Abaxonal appositions (arrows). Note the diffuse DRP2 staining and paucity of appositions in OGT-SCKO nerve. The nodes of Ranvier (arrowheads) and the SC nucleus (asterisk) are labeled. Scale bar,
10m. C, Electron micrograph showing myelinated fibers of sciatic nerve in a cross section from 1-month-old control and OGT-SCKO mice. Pairs of arrowheads mark the abaxonal appositions
residing between the compact myelin and SC plasmamembrane. Note the lack of abaxonal appositions in the OGT-SCKO fiber. Scale bar, 1m.D, Quantification of abaxonal appositions displayed
as average per myelinated fiber in nerves from B. Note the dramatic decrease in appositions in OGT-SCKO mice. Approximately 30 fibers per mouse were analyzed; n 3 mice per genotype.
E, Representative confocalmicroscopic imagesdepicting the entire internodal lengthofmyelinated fibers from3-month-old control andOGT-SCKOnerves labeled forNAV1.6 (green),MBP (red), and
DAPI (blue). Note the decrease in intermodal length in the OGT-SCKO nerve (n 3 mice per genotype, 10 fibers per mouse). Arrowheads mark the node of Ranvier. Scale bar, 100m.
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Figure 6. O-GlcNAcylation is required for proper PRX localization but does not affect DRP2–PRX interaction. A, Western blot analysis of PRX, DRP2, and-Dystroglycan in sciatic nerves from
1-month-old control and OGT-SCKO mice. DGa,-Dystroglycan; GAPDH, glyceraldehyde-3-phosphodehydrogenase; Actin,-actin; Tubulin,-tubulin. Note the decrease in the DRP2 level in the
OGT-SCKO nerve. B, Quantification of PRX, DRP2, and DGa in A. Normalized by GAPDH (n 3 mice per genotype). Data are represented as mean SEM. Student’s t test, ***p 0.001); ns, not
significant.C,D, Coimmunoprecipitation analysis of interaction betweenPRXandDRP2. Nerve lysateswere immunoprecipitated for DRP2 (C) or PRX (D). The boundpartnerwas detectedbyWestern
blotting with indicated antibody. IP, Immunoprecipitation; IgG, preimmune rabbit sera. A total of 2.5% of the lysate was used for input control (Input). Note that the PRX–DRP2 interaction was
maintained in OGT-SCKO nerve lysates. E–H, Localization of PRX in Ctrl and OGT-SCKO (ogt) sciatic nerves. E, F, Representative confocalmicroscopic images of teased fibers (E) and cross sections (F),
stained for PRX (green) and MBP (red). E, In teased fiber preparations, PRX distributes as elongated coarse streaks (arrows) along the myelin sheath in OGT-SCKO nerves, whereas it localizes to
apposition-like features (arrows) in controls. The nodes of Ranvier (arrowheads) and the SC nucleus (asterisk) are labeled. The area enclosed by the dashed line (inset) was enlarged to highlight
appositions in control and the corresponding area in the mutant. F, In cross sections, PRX concentrates peripherally to MBP (arrows) in control nerves, whereas PRX andMBP overlap extensively in
OGT-SCKO nerves. G, Line-plot profile of PRX and MBP distribution across the myelin sheath in F. Pixel intensities of PRX and MBP on a straight line drawn across the (Figure legend continues.)
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cate that the O-GlcNAcylation state does not have amajor effect on
DRP2–PRX complex formation.
PRX has a more widespread distribution than DRP2 within
the nerve: it first translocates from the nucleus to the adaxonal
(inner) surface and, as SCsmature, is later found on the abaxonal
surface of the myelin sheath (Gillespie et al., 1994; Scherer et al.,
1995; Sherman and Brophy, 2000; Sherman et al., 2001).We next
examined whether the lack of O-GlcNAcylation alters PRX sub-
cellular localization (Fig. 6E–H).We consistently found that PRX
is localized to membrane appositions in control nerves (Fig. 6E),
although it ismore diffusively distributed thanDRP2 (Fig. 5B). In
OGT-SCKO nerves, PRX is diffusely localized at the abaxonal
surface but is present in elongated patches with ill-defined bor-
ders, suggesting a role of O-GlcNAcylation in the localization of
PRX at a late stage of myelination. In cross sections, a significant
fraction of PRX can clearly be seen peripheral to the MBP distri-
bution in control nerves (Fig. 6F). However, in OGT-SCKO
nerves, PRX distributed diffusively and overlapped with MBP
throughout the width of the myelin sheath. By quantification of
the relative distribution of PRX toMBP across the myelin sheath
(Fig. 6G,H), we confirmed the extensive overlap between PRX
and MBP in OGT-SCKO nerves as well as the clearly segregated
distribution in wild-type nerves. In particular, the demarcated
peak distribution of PRX and MBP normally observed in wild-
type nerves is lost in OGT-SCKO nerves (Fig. 6H). In summary,
these observations indicate that O-GlcNAc modification is re-
quired for proper localization of PRX to abaxonal appositions in
myelinated fibers.
Discussion
Our studies reveal a crucial role for SC O-GlcNAcylation in
mediating axon–glial interactions in the peripheral nervous
system. Importantly, SCs with deficient O-GlcNAcylation
did not form normal myelin or provide adequate support
to maintain axon integrity. In a mass spectrometry analysis of
the O-GlcNAc proteome in rat sciatic nerve, we identified the
myelin protein PRX as an O-GlcNAcylated protein. The
OGT-SCKO and Prx mutant mice both develop tomaculous
demyelinating peripheral neuropathy with similar features.
Furthermore, specific functions of PRX were impaired in
OGT-SCKO nerves, including the formation of membrane
appositions and Cajal bands as well as the shortened inter-
nodes reflective of poor SC elongation.
OGT-SCKOmice as a model of tomaculous demyelinating
peripheral neuropathy
Tomacula, focal thickenings of myelin, are a peculiar clinical
manifestation that is observed in a number of inherited demyeli-
nating peripheral neuropathies. Several mechanisms have been
proposed to explain tomacula formation, including hypermyeli-
nation, formation of redundant myelin loops, presence of a sec-
ondmesaxon, transnodalmyelination,multiple SCs forming one
myelin sheath, and myelin sheath disruption (Sander et al.,
2000). InOGT-SCKOnerves, tomacula aremostly infoldings and
outfoldings of the myelin sheath and are localized at the jux-
taparanodal/paranodal regions. Tomacula formation in OGT-
SCKO sciatic nerves begins at6weeks of age and peaks at3–4
months. This timing is similar to that observed in Prx mutant
mice. However, it is distinct from the early postnatal appearance
of tomacula in Pmp22 mutant mice that serve as a model of
HNPPs, which is associated with tomacula formation (Adlkofer
et al., 1995; Gillespie et al., 2000). Tomaculous neuropathy is also
observed in mice with SC-specific loss of Pten and correspond-
ingly increased levels of pAkt (Goebbels et al., 2012). In accord,
the myelin abnormalities in these nerves are suppressed by treat-
ingwith rapamycin to inhibitmechanistic target of rapamycin. In
contrast, pAkt levels are not increased in OGT-SCKO nerves and
nerve abnormalities inOGT-SCKOmice are not rescued by rapa-
mycin treatment (data not shown). Clearly, tomacula can form
through perturbation of multiple pathways, and developing ef-
fective treatments will require an understanding of how these
pathways intersect to cause myelin overgrowth.
The functional consequences of tomacula formation are per-
plexing despite the simplified assertion of tomacula as a myelin
abnormality. Studies from many years ago demonstrated that
relative myelin thickness, as measured via g-ratios, is carefully
calibrated for optimal effective nerve conduction (Smith and
Koles, 1970). This implies that alterations from the normal
g-ratios in disease conditions will result in slower conduction
velocity, such as that which occurs in the absence of OGT. How-
ever, in our physiological studies, we found that nerve conduc-
tion deficits begin before the development of tomacula. In
addition, moderate conduction velocities were maintained even
as the number of tomacula continued to increase dramatically
with age. Similarly, nerve function in Drp2 mutant mice re-
mained normal despite an age-dependent increase in tomacula
formation (Sherman et al., 2012). Overall, these observations im-
ply that tomacula formation itself does not necessarily cripple
peripheral nerve function and that additional damagemust occur
to affect conduction velocity.
O-GlcNAc regulation of PRX inmyelinating SCs
In our mass spectrometry analysis of the rat sciatic nerve
O-GlcNAc proteome, we identified PRX as a SC-specific
O-GlcNAcylated protein. An important molecular aspect of PRX
is its concentration at the abaxonal appositions along the myelin
fibers (Gillespie et al., 1994). In this study, we showed that the
localization of PRX is anO-GlcNAcylation-dependent process in
that PRX lacking this modification is not properly localized. The
lack of O-GlcNAcylation did not significantly alter PRX levels or
its interaction with DRP2; thus, these twomechanisms cannot be
invoked to explain howO-GlcNAcylationmediates PRX localiza-
tion. Speculatively, O-GlcNAcylation of PRXmay alter the acces-
sibility of a potential interface that is necessary to interactwith the
translocation machinery. To address this problem, mutational
studies to identify the critical O-GlcNAcylated residues required
for PRX localization will be necessary along with other studies to
identify proteins involved in this process.
Our proteomic analysis did not identify O-GlcNAc modifica-
tion of other abundant myelin proteins (e.g., MPZ, PMP22);
however, we did find otherO-GlcNAcylated proteins in the nerve
that are expressed by SCs andwhose function could be affected by
mutation of OGT. Altered function of these proteins could also
contribute to the neuropathy observed in OGT-SCKO mice.
With regard to PRX, its role in the formation of Cajal bands,
which are SC cytoplasm-filled channels, suggests that it could
play a unique role in coupling metabolism to myelin mainte-
nance and nerve function (Nave, 2010). For example, because
4
(Figure legend continued.) myelin sheathwere first aligned according to the peak coordinate
ofMBPper genotype, then averaged andnormalized to themax intensity per protein. Note that
PRX and MBP extensively overlap in OGT-SCKO nerves but are segregated in control nerves. H,
Quantification of the location of PRX peaks fromMBP inG. Twentymyelinated fibers from three
mice per genotype were examined. Data are represented as mean SEM. Student’s t test,
***p 0.001. Scale bars: E, 10m; F, 5m.
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glucose and other metabolites are primarily sealed from the axon
by themyelin sheath, these channels constitute an access point for
axonal energy sources and could provide a mechanism for PRX
regulation of axonal stability. Furthermore, microtubule-based
transport in Cajal bands has been proposed to promote SC elon-
gation, another PRX-dependent process, that accompanies ax-
onal growth (Court et al., 2004). OGT, which is regulated by
glucose concentration, provides a means to connect SC metabo-
lism with the PRX-dependent processes involved in myelin for-
mation/maintenance. In this scenario, O-GlcNAc-dependent
localization of PRX at the abaxonal (outer) surface of themyelin-
ated fiber would signal that the metabolic environment is suffi-
cient for the SC to engage in myelination and provide axonal
support. This may be important in diseases caused by altered
metabolism such as in mitochondrial deficiency syndromes and
diabetes, both of which are frequently associated with peripheral
neuropathy.
In summary, this study identifies OGT activity as an impor-
tant regulator of SC functions such as myelin maintenance and
axonal support. We further propose that O-GlcNAcylation of
PRX contributes to the OGT regulation of SC function. We an-
ticipate that theOGT-SCKOmicewill be useful in understanding
howSCmetabolism contributes to PNS function and, perhaps, in
developing new strategies for treating peripheral neuropathy by
targeting SC function.
Notes
Supplemental material for this article is available at http://prospector2.ucsf.
edu/prospector/cgi-bin/msform.cgi?formmsviewer. O-GlcNAc proteme
of rat sciatic nerve can be viewed in MS_Viewer at the provided website
(search keys: ETD, ntrqixzaiv; HCD, fcx3docywo) This material has not
been peer reviewed.
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